Katherine L. Wisner, MD, MS1; Paul S. Appelbaum, MD2
doi : 10.1001/jamapsychiatry.2022.4962
April 2023, Vol 80, No. 4, Pages 283-402
Randall L. Kuffel, BS; Ruth T. Morin, PhD; Kenneth E. Covinsky, MD, MPH; et al.
Kristin Köhler-Forsberg, PhD1,2,3; Vibeke H. Dam, PhD1,2; Brice Ozenne, PhD1,4; Anjali Sankar, PhD1; Vincent Beliveau, PhD1,5; Elizabeth B. Landman, MD1; Søren V. Larsen, MD1,2; Asbjørn S. Poulsen, MD1; Cheng-Teng Ip, PhD1,2,6; Anders Jørgensen, PhD2,3; Michal Meyer, BSc7; Dea S. Stenbæk, PhD1,8; Hans R. L. Eiberg, MSc9; Jacob Madsen, PhD10; Claus Svarer, PhD1; Martin B. Jørgensen, MD, DMSc1,2,3; Vibe G. Frokjaer, MD, PhD1,2,3; Gitte M. Knudsen, DMSc1,2
doi : 10.1001/jamapsychiatry.2022.4539
Importance The cerebral serotonin 4 (5-HT4) receptor is a promising novel target for treatment of major depressive disorder (MDD), and pharmacological stimulation of the 5-HT4 receptor has been associated with improved learning and memory in healthy individuals.
Teng Yang, BD1; Jiawei Wang, BD1; Jing Huang, PhD1,2; Frank J. Kelly, PhD3; Guoxing Li, PhD1,3
doi : 10.1001/jamapsychiatry.2022.4812
Importance Air pollution is increasingly recognized as an important environmental risk factor for mental health. However, epidemiologic evidence on long-term exposure to low levels of air pollutants with incident depression and anxiety is still very limited.
Kenneth S. Kendler, MD1,2; Linda Abrahamsson, PhD3; Henrik Ohlsson, PhD3; Jan Sundquist, MD, PhD3,4,5; Kristina Sundquist, MD, PhD3,4,5
doi : 10.1001/jamapsychiatry.2022.4777
Importance We know little about the transmission of obsessive-compulsive disorder (OCD) across generations.
Josef Isung, MD, PhD1,2; Kayoko Isomura, MD, PhD1,2; Kyle Williams, MD, PhD3,4; Tianyang Zhang, PhD1,2; Paul Lichtenstein, PhD5; Lorena Fernández de la Cruz, PhD1,2; Anna Sidorchuk, MD, PhD1,2; David Mataix-Cols, PhD1,2
doi : 10.1001/jamapsychiatry.2022.4786
Importance Maternal immune activation (MIA) leading to altered neurodevelopment in utero is a hypothesized risk factor for psychiatric outcomes in offspring. Primary antibody immunodeficiencies (PIDs) constitute a unique natural experiment to test the MIA hypothesis of mental disorders.
Lyna Z. Schieber, MD, DPhil1; Christopher Dunphy, PhD2; Richard A. Schieber, MD, MPH3; Barbara Lopes-Cardozo, MD, MPH4; Ramal Moonesinghe, PhD5; Gery P. Guy Jr, PhD, MPH1
doi : 10.1001/jamapsychiatry.2022.5047
Importance During the COVID-19 pandemic, US emergency department (ED) visits for psychiatric disorders (PDs) and drug overdoses increased. Psychiatric disorders and substance use disorders (SUDs) independently increased the risk of COVID-19 hospitalization, yet their effect together is unknown.
Thomas T. van Sloten, MD1; Eugénie Valentin, MSc2; Rachel E. Climie, PhD2,3; Xavier Jouven, MD2; Cedric Lemogne, MD4,5; Marcel Goldberg, MD6; Marie Zins, MD4; Jean-Philippe Empana, MD2
doi : 10.1001/jamapsychiatry.2022.5056
Importance Cardiovascular health may be used for prevention of depressive symptoms. However, data on the association of cardiovascular health across midlife with depressive symptoms are lacking.
Frederikke Hørdam Gronemann, PhD, Msc1; Rikke Kart Jacobsen, Msc1; Marie Kim Wium-Andersen, DMSc1; Martin Balslev Jørgensen, DMSc2; Merete Osler, DMSc1,3; Terese Sara Høj Jørgensen, PhD, Msc1,4
doi : 10.1001/jamapsychiatry.2022.4965
Importance Major depression (MD) aggregates within families, but how family history of MD confers risk of MD over the life course is unclear. Such knowledge is important to identify and prevent possible depressogenic effects of family environment.
Weiming Gong, MM1,2; Ping Guo, MM1,2; Yuanming Li, BM3; Lu Liu, PhD1,2; Ran Yan, PhD1,2; Shuai Liu, MM1,2; Shukang Wang, MD, PhD1,2; Fuzhong Xue, PhD1,2; Xiang Zhou, PhD4,5; Zhongshang Yuan, PhD1,2
doi : 10.1001/jamapsychiatry.2022.4974
Importance Comorbidities and genetic correlations between gastrointestinal tract diseases and psychiatric disorders have been widely reported, with the gut-brain axis (GBA) hypothesized as a potential biological basis. However, the degree to which the shared genetic determinants are involved in these associations underlying the GBA is unclear.
Helene Gjervig Hansen, MD1,2; Marie Starzer, MD1,2; Sandra Feodor Nilsson, PhD1; Carsten Hjorthøj, PhD1,3; Nikolai Albert, PhD1,4; Merete Nordentoft, DrMedSc1,2
doi : 10.1001/jamapsychiatry.2022.5164
Importance The OPUS 20-year follow-up is the longest follow-up of a randomized clinical trial testing early intervention services (EIS) among individuals with first-episode schizophrenia spectrum disorder.
Deborah S. Hasin, PhD1; Melanie M. Wall, PhD1; C. Jean Choi, MS2; Daniel M. Alschuler, MS2; Carol Malte, MSW3,4; Mark Olfson, MD, MPH1; Katherine M. Keyes, PhD5; Jaimie L. Gradus, DMSc, DSc6; Magdalena Cerdá, DrPH7; Charles C. Maynard, PhD8; Salomeh Keyhani, MD9; Silvia S. Martins, MD, PhD5; David S. Fink, PhD10; Ofir Livne, MD, MPH5; Zachary Mannes, PhD5; Scott Sherman, MD11; Andrew J. Saxon, MD8
doi : 10.1001/jamapsychiatry.2023.0019
Importance Cannabis use disorder (CUD) is increasing among US adults. Few national studies have addressed the role of medical cannabis laws (MCLs) and recreational cannabis laws (RCLs) in these increases, particularly in patient populations with high rates of CUD risk factors.
Marta Peciña, MD, PhD1; Jiazhou Chen, BS2,3; Jordan F. Karp, MD4; Alexandre Y. Dombrovski, MD1
doi : 10.1001/jamapsychiatry.2023.0010
Importance Despite high antidepressant placebo response rates, the mechanisms underlying the persistence of antidepressant placebo effects are still poorly understood.
Santiago Papini, PhD1; Honor Hsin, MD, PhD2; Patricia Kipnis, PhD1; Vincent X. Liu, MD, MS1; Yun Lu, MD, MPH1; Stacy A. Sterling, DrPH, MSW, MPH1; Esti Iturralde, PhD1
Peter Andersson, MSc1; Håkan Jarbin, PhD2; Adrian Emmanuel Desai Boström, PhD3,4
Miriam I. Martini, MSc1; Agnieszka Butwicka, PhD1,2,3,4; Mark Taylor, PhD1
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟